Table 4 Protective potency of the expressed peptide vaccine against lethal challenge by CSFV Shimen strain.
Group | Vaccination | Clinical sign | Morbidity (%) | Mortality (%) | Protection Ratio (%) | ||
|---|---|---|---|---|---|---|---|
Petechial heamorrhages | Diarrhea | Endothelial damage | |||||
A | rE2-a | 1/5 | 1/5 | 1/5 | 20 | 20 | 80 |
B | rE2-b | 0/5 | 0/5 | 0/5 | 0 | 0 | 100 |
C | rE2-ba | 0/5 | 0/5 | 0/5 | 0 | 0 | 100 |
D | HCLV | 0/5 | 0/5 | 0/5 | 0 | 0 | 100 |
E | PBS | 5/5 | 5/5 | 5/5 | 100 | 100 | 0 |